Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Overcoming the Cost Barrier for Thalassemia Innovative Treatments

Angela Vitrano, Rita Barone, Antonino Giangreco, Rosario Di Maggio, Luca Castagna, Gianluca Forni, Emanuele Angelucci, Franco Locatelli, Aurelio Maggio

Blood (2023) 142 (Supplement 1): 5200.

https://doi.org/10.1182/blood-2023-180708

Published: 2023

Journal Articles

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-139196

Published: 2020

Journal Articles

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Rosario Di Maggio, MD, Angela Vitrano, PhD, Carmelo Fidone, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Calogera Gerardi, MD, Saveria Campisi, MD, Lorenzo Tesé, MD, Vincenzo Santoro, MD, Barone Rita, MD, Giangreco Antonino, MD, Paolo Rigano, Lorella Pitrolo, MD, Aurelio Maggio, MD

Blood (2019) 134 (Supplement_1): 4810.

https://doi.org/10.1182/blood-2019-124728

Published: 2019

Journal Articles

Development of a Severity Score System for Thalassemia Syndromes

Blood (2019) 134 (Supplement_1): 2225.

https://doi.org/10.1182/blood-2019-124675

Published: 2019

Journal Articles

Is the Time of Revisiting Classification of Thalassemia Syndromes According with the Phenotype Severity?

Angela Vitrano, PhD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Alessia Pepe, MD, Antonella Meloni, PhD, Laura Pistoia, MD, Maria Rita Gamberini, MD, Vincenzo Caruso, MD, Aldo Filosa, MD, Paolo Ricchi, MD, Liana Cuccia, MD, Domenico D'Ascola, MD, Francesco Sorrentino, MD, Angelo Peluso, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 935.

https://doi.org/10.1182/blood.V130.Suppl_1.935.935

Published: 2017

Journal Articles

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Angela Vitrano, PhD, Massimiliano Sacco, DR, Rosamaria Rosso, MD, Alessandra Quota, MD, Daniela Fiorino, MD, Esther Natalie Oliva, MD, Calogera Gerardi, MD, Gaetano Roccamo, MD, Vincenzo Spadola, MD, Aldo Filosa, MD, Lorenzo Tesé, MD, Giuseppina Calvaruso, MD, Lorella Pitrolo, MD, Laura Mistretta, DR, Filippo Cassarà, DR, Rosario Di Maggio, MD, Aurelio Maggio, MD

Blood (2017) 130 (Supplement 1): 936.

https://doi.org/10.1182/blood.V130.Suppl_1.936.936

Published: 2017

Journal Articles

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Alice Pecoraro, DR, Angela Vitrano, PhD, Antonio Troia, DR, Maria Fustaneo, MD, Lorella Pitrolo, MD, Paolo Rigano, MD, Aurelio Maggio, MD, Rosalba Di Marzo, DR

Blood (2016) 128 (22): 4821.

https://doi.org/10.1182/blood.V128.22.4821.4821

Published: 2016

Journal Articles

Diastolic Dysfunction with Normal Heart T2* in Thalassemia Major with Heart Failure. a Single Centre Study

Luigi Mancuso, MD, Angela Vitrano, PhD, Massimiliano Sacco, Dr, Andrea Mancuso, MD, Antonietta Ledda, MD, Aurelio Maggio, MD

Blood (2016) 128 (22): 2457.

https://doi.org/10.1182/blood.V128.22.2457.2457

Published: 2016

Journal Articles

Study on the Efficacy of a JAK Inhibitor Pharmacological Agent As Inducer of Fetal Hemoglobin Production in Cultured Erythroid Precursors from Sickle Cell and Beta-Thalassemia Patients

Alice Pecoraro, Antonio Troia, Angela Vitrano, Rosario Di Maggio, Massimiliano Sacco, Aurelio Maggio, Rosalba Di Marzo

Blood (2015) 126 (23): 2048.

https://doi.org/10.1182/blood.V126.23.2048.2048

Published: 2015

Journal Articles

Earlier Antenatal Diagnosis of Hemoglobinopathies By Coelocentesis

Antonino Giambona, Gianfranca Damiani, Filippo Leto, Cristina Yakil, Cristina Passarello, Valentina Cigna, Giovanna Schillaci, Massimiliano Sacco, Rosario Di Maggio, Angela Vitrano, Aurelio Maggio

Blood (2015) 126 (23): 2133.

https://doi.org/10.1182/blood.V126.23.2133.2133

Published: 2015

Journal Articles

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Blood (2015) 126 (23): 2141.

https://doi.org/10.1182/blood.V126.23.2141.2141

Published: 2015

Journal Articles

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Veronica Agrigento, Sclafani Serena, Paolo Rigano, Rita Barone, Giuseppina Calvaruso, Rosario Di Maggio, Massimiliano Sacco, Lorella Pitrolo, Angela Vitrano, Aurelio Maggio, Elena D'Alcamo

Blood (2015) 126 (23): 2142.

https://doi.org/10.1182/blood.V126.23.2142.2142

Published: 2015

Journal Articles

Different Thresholds of Serum Ferritin Levels for Prediction of Liver Iron Concentration in Hemoglobinopathies

Blood (2015) 126 (23): 2146.

https://doi.org/10.1182/blood.V126.23.2146.2146

Published: 2015

Journal Articles

The Challenge of Using CB-HSCs As Source for Gene Therapy: Lentiviral Vector Transduction, Phenotypic Characterization and Global Gene Expression Profile of Ex-Vivo Expanded CB CD34+ Cells

Rosalia Di Stefano, Elena Baiamonte, Melania Lo Iacono, Barbara Spina, Flavia Contino, Claudia Coronnello, Massimiliano Sacco, Rosario Di Maggio, Angela Vitrano, Salvatore Feo, Aurelio Maggio, Santina Acuto

Blood (2015) 126 (23): 5548.

https://doi.org/10.1182/blood.V126.23.5548.5548

Published: 2015

Journal Articles

Wharton's Jelly- MSC As Effective Tool for Expansion of Purified Human Cord Blood CD34+ Hematopoietic Stem Cells

Melania Lo Iacono, Elena Baiamonte, Rosalia Di Stefano, Barbara Spina, Massimiliano Sacco, Rosario Di Maggio, Angela Vitrano, Aurelio Maggio, Santina Acuto

Blood (2015) 126 (23): 4770.

https://doi.org/10.1182/blood.V126.23.4770.4770

Published: 2015

Journal Articles

Mesenchymal Fetal Stem Cells (FMSC) from Amniotic Fluid (AF): Expansion and Phenotypic Characterization

Maria Concetta Renda, Emanuela Fecarotta, Giovanna Schillaci, Filippo Leto, Giuseppina Calvaruso, Giuseppa Maria Garofalo, Angela Piazza, Massimiliano Sacco, Rosario Di Maggio, Angela Vitrano, Aurelio Maggio

Blood (2015) 126 (23): 4758.

https://doi.org/10.1182/blood.V126.23.4758.4758

Published: 2015

Journal Articles

Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yields of CD34+ Cells with Primitive Signatures

Elena Baiamonte, Rita Barone, Rosalia Di Stefano, Melania Lo Iacono, Barbara Spina, Flavia Contino, Rosario Di Maggio, Massimiliano Sacco, Angela Vitrano, Salvatore Feo, Aurelio Maggio, Santina Acuto

Blood (2015) 126 (23): 4412.

https://doi.org/10.1182/blood.V126.23.4412.4412

Published: 2015

Journal Articles

The Sea Urchin sns5 Chromatin Insulator Improves the Likelihood of Lentiviral Vectors in Erythroid Milieu By Organizing an Independent Chromatin Domain at the Integration Site

Elena Baiamonte, Rosalia Di Stefano, Melania Lo Iacono, Barbara Spina, Angela Vitrano, Rosario Di Maggio, Massimiliano Sacco, Giovanni Spinelli, Aurelio Maggio, Santina Acuto, Vincenzo Cavalieri

Blood (2015) 126 (23): 4414.

https://doi.org/10.1182/blood.V126.23.4414.4414

Published: 2015

Journal Articles

Central Role of LIC-R2 (Ferriscan®) Determination in Patients with Hemoglobinopathies: Licnet Experience

Blood (2014) 124 (21): 4034.

https://doi.org/10.1182/blood.V124.21.4034.4034

Published: 2014

Journal Articles

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Blood (2014) 124 (21): 1354.

https://doi.org/10.1182/blood.V124.21.1354.1354

Published: 2014

NARROW

Overcoming the Cost Barrier for Thalassemia Innovative Treatments

Three Distinct Groups of Phenotype Severity in Beta-Thalassemia

LIC-R2 Values Predict Severity of SCD: Baseline Data from Licnet-S

Development of a Severity Score System for Thalassemia Syndromes

Is the Time of Revisiting Classification of Thalassemia Syndromes According with the Phenotype Severity?

Inadequacy of Ferritin Trends for Predicting Changes in LIC Risk Category in Transfusion Depedent and Well Chelated Patients with Haemoglobinopathies

Lower Levels of LPI in Thalassemia Major Patients Treated with Deferasirox

Diastolic Dysfunction with Normal Heart T2* in Thalassemia Major with Heart Failure. a Single Centre Study

Study on the Efficacy of a JAK Inhibitor Pharmacological Agent As Inducer of Fetal Hemoglobin Production in Cultured Erythroid Precursors from Sickle Cell and Beta-Thalassemia Patients

Earlier Antenatal Diagnosis of Hemoglobinopathies By Coelocentesis

Survival Comparability Between Thalassemia Major Versus Thalassemia Intermedia

Congenital Dyserythropoietic Anemias: Molecular Diagnosis and Diagnostic Approach in a Cohort of Italian Patients

Different Thresholds of Serum Ferritin Levels for Prediction of Liver Iron Concentration in Hemoglobinopathies

The Challenge of Using CB-HSCs As Source for Gene Therapy: Lentiviral Vector Transduction, Phenotypic Characterization and Global Gene Expression Profile of Ex-Vivo Expanded CB CD34+ Cells

Wharton's Jelly- MSC As Effective Tool for Expansion of Purified Human Cord Blood CD34+ Hematopoietic Stem Cells

Mesenchymal Fetal Stem Cells (FMSC) from Amniotic Fluid (AF): Expansion and Phenotypic Characterization

Hematopoietic Stem Cell Mobilization for Gene Therapy: The Combination of G-CSF+Plerixafor in Patients with Beta-Thalassemia Major Provides High Yields of CD34+ Cells with Primitive Signatures

The Sea Urchin sns5 Chromatin Insulator Improves the Likelihood of Lentiviral Vectors in Erythroid Milieu By Organizing an Independent Chromatin Domain at the Integration Site

Central Role of LIC-R2 (Ferriscan®) Determination in Patients with Hemoglobinopathies: Licnet Experience

Deferiprone Versus Deferoxamine in Thalassemia Intermedia: Results from 5-Year Long-Term Italian Multi-Center Randomized Clinical Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only